Intellectual Property India Publishes Patent Application for 'Antigen-Capturing Nanoparticles And Formulations For Immunotherapy' Filed by Archimmune Therapeutics, Inc.

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517073456 A) filed by Archimmune Therapeutics, Inc., Woburn, U.S.A., on Aug. 1, for 'antigen-capturing nanoparticles and formulations for immunotherapy.'

Inventor(s) include Ren, Hong; Svenson, Sonke; Qian, Dapeng; and Wang, Andrew.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides novel antigen-capturing nano-particles (ACNPs) and pharmaceutical formulations containing such ACNPs. Also provided herein are methods for preparing the ACNP formulations, and methods for the treatment of a disease (such as cancer) in a subject with the ACPNs or a pharmaceutical formulation containing the ACPNs."

The patent application was internationally filed on Feb. 06, 2024, under International application No.PCT/US2024/014664.

Disclaimer: Curated by HT Syndication.